| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA approves first generic naloxone nasal spray to treat opioid overdose
USA. FDA approves first generic naloxone nasal spray to treat opioid overdose
Agency is also taking new steps to support development of over-the-counter and additional generics of naloxone to help reduce opioid overdose deaths, increase access to emergency treatment. (FDA – US Fodd and Drug Administration, 19.04.2019)